Silver Book Fact

The total economic burden of coronary heart disease is $120.6 billion; of stroke is $48.9 billion.

Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux. The Value Of Antihypertensive Drugs: A perspective on medical innovation. Health Affairs. 2007; 26(1): 97-110

Reference

Title
The Value Of Antihypertensive Drugs: A perspective on medical innovation
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Cutler, David M., Genia Long, Ernst R. Berndt, Jimmy Royer, Andree-Anne Fournier, Alicia Sasser, and Pierre Cremieux
Volume & Issue
Volume 26, Issue 1
Pages
97-110

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • 1/4 of all deaths in the U.S. are attributable to heart disease.  
  • AFib patients over age 80, 2050
    By 2050, it is estimated that more than 50% of Americans with atrial fibrillation will be age 80 and older.  
  • In-hospital deaths caused by venous thromboembolism
    The number of in-hospital deaths that are caused by venous thromboembolism is more than five times the number of deaths caused by all hospital-acquired infections.  
  • Close to 50% of Americans 45 or older have high blood pressure.  
  • In 2009, the estimated direct and indirect cost of cardiovascular disease is $165.4 billion.